Janssen Scientific Affairs, LLC Clinical Trial
Janssen Scientific Affairs, LLC · Ortho-McNeil Janssen Scientific Affairs, LLC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Janssen Scientific Affairs, LLC Clinical Trial as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:09 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06052319 · A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) PopulationJanssen Scientific Affairs, LLC · completed · Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD) · study director
- Ph2NCT05347485 · A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple MyelomaJanssen Scientific Affairs, LLC · completed · Multiple Myeloma · study director
- Ph4NCT04442737 · A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight GainJanssen Scientific Affairs, LLC · completed · HIV-1 · study director
- N/ANCT04372108 · A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative ColitisJanssen Scientific Affairs, LLC · recruiting · Crohn Disease, Colitis, Ulcerative · study director
- N/ANCT04276441 · A Study to Investigate if Early Atrial Fibrillation (AF) Diagnosis Reduces Risk of Events Like Stroke in the Real-WorldJanssen Scientific Affairs, LLC · completed · Atrial Fibrillation · study director
- N/ANCT03825484 · Expanded Access Program (EAP) for Participants With Advanced Cancers and Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations Who Have Exhausted All Treatment OptionsJanssen Scientific Affairs, LLC · approved for marketing · Advanced Cancers and FGFR Genetic Alterations · study director
- N/ANCT03571685 · Sustainable Early Episode Clinic Study (SEEC)Janssen Scientific Affairs, LLC · completed · Schizophrenia, Schizoaffective Disorder · study director
- Ph3NCT03464136 · Safety and Efficacy of Adalimumab Versus Ustekinumab for One YearJanssen Scientific Affairs, LLC · completed · Crohn Disease · study director
- N/ANCT03382613 · A Study to Quantify Use of Anticoagulation to Improve Management of Atrial FibrillationJanssen Scientific Affairs, LLC · terminated · Atrial Fibrillation · study director
- Ph3NCT03227861 · A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of CareJanssen Scientific Affairs, LLC · completed · HIV-1 · study director
- N/ANCT03180853 · Multiple Myeloma Patient RegistryJanssen Scientific Affairs, LLC · terminated · Multiple Myeloma · study director
- N/ANCT03085108 · A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior AssessmentJanssen Scientific Affairs, LLC · completed · Suicidality · study director
- Ph4NCT02996435 · Smartphones to Improve Rivaroxaban ADHEREnce in Atrial FibrillationJanssen Scientific Affairs, LLC · completed · Atrial Fibrillation · study director
- Ph1NCT02984852 · Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult ParticipantsJanssen Scientific Affairs, LLC · completed · Healthy · study director
- Ph2NCT02951819 · A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple MyelomaJanssen Scientific Affairs, LLC · completed · Multiple Myeloma · study director
- N/ANCT02728934 · Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid ArthritisJanssen Scientific Affairs, LLC · completed · Arthritis, Rheumatoid · study director
- N/ANCT02663193 · Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) TolerabilityJanssen Scientific Affairs, LLC · completed · Prostate Cancer · study director
- N/ANCT02600741 · Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)Janssen Scientific Affairs, LLC · completed · Schizophrenia · study chair
- Ph4NCT02584660 · A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency DepartmentJanssen Scientific Affairs, LLC · completed · Pulmonary Embolism · study director
- Ph4NCT02566889 · An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel DiseaseJanssen Scientific Affairs, LLC · terminated · Inflammatory Bowel Diseases · study director
- Ph1NCT02561923 · A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy ParticipantsJanssen Scientific Affairs, LLC · completed · Healthy · study director
- Ph3NCT02431702 · A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or SchizophreniformJanssen Scientific Affairs, LLC · completed · Schizophrenia, Psychotic Disorders · study director
- Ph1NCT02307864 · Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy ParticipantsJanssen Scientific Affairs, LLC · completed · Healthy · study director
- Ph2NCT02165189 · An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver TransplantJanssen Scientific Affairs, LLC · completed · Hepatitits C · study director
- N/ANCT02103699 · A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With SimeprevirJanssen Scientific Affairs, LLC · completed · Hepatitis C Virus · study director
- Ph1NCT01947920 · A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy VolunteersJanssen Scientific Affairs, LLC · completed · Healthy · study director
- Ph4NCT01939496 · Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive AgentsJanssen Scientific Affairs, LLC · completed · Diabetes Mellitus, Type 2, Hypertension · study director
- Ph3NCT01830543 · A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary InterventionJanssen Scientific Affairs, LLC · completed · Atrial Fibrillation, Percutaneous Coronary Intervention · study director
- Ph3NCT01729871 · A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation TherapyJanssen Scientific Affairs, LLC · completed · Atrial Fibrillation · study director
- N/ANCT01701817 · Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)Janssen Scientific Affairs, LLC · completed · Atrial Fibrillation · study director
- Ph4NCT01631513 · An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)Janssen Scientific Affairs, LLC · withdrawn · Pain, Chronic Back Pain, Chronic Low Back Pain · study director
- Ph1NCT01464450 · Pharmacokinetics Study of Oral Rivaroxaban in Healthy ParticipantsJanssen Scientific Affairs, LLC · completed · Pharmacokinetics, Bioavailability, Healthy Participants · study director
- Ph4NCT01193166 · Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric HospitalOrtho-McNeil Janssen Scientific Affairs, LLC · withdrawn · Schizophrenia · study director
- Ph3NCT01193153 · A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective DisorderJanssen Scientific Affairs, LLC · completed · Schizoaffective Disorder · study director
- N/ANCT01181960 · Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health OrganizationsJanssen Scientific Affairs, LLC · completed · Schizophrenia, Bipolar Disorder · study director
- N/ANCT01165710 · Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Janssen Scientific Affairs, LLC · completed · Atrial Fibrillation · study director
- Ph4NCT01157351 · 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and IncarceratedJanssen Scientific Affairs, LLC · completed · Schizophrenia · study director
- Ph3NCT01094886 · Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee ReplacementOrtho-McNeil Janssen Scientific Affairs, LLC · completed · Arthritis, Osteoarthritis, Knee, Osteoarthritis, Hip · study director
- Ph2NCT00990886 · The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal WomenOrtho-McNeil Janssen Scientific Affairs, LLC · completed · Menopause, Hot Flashes · study director
- Ph3NCT00986180 · NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back PainOrtho-McNeil Janssen Scientific Affairs, LLC · completed · Pain, Back Pain, Low Back Pain · study director
- N/ANCT00978328 · Oxycodone User Registry (OUR)Ortho-McNeil Janssen Scientific Affairs, LLC · completed · Pain · study director
- Ph4NCT00946985 · 28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 YearsOrtho-McNeil Janssen Scientific Affairs, LLC · terminated · Schizophrenia · study director
- Ph4NCT00937040 · Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD)Ortho-McNeil Janssen Scientific Affairs, LLC · completed · Attention Deficit Disorder With Hyperactivity · study director
- Ph3NCT00855335 · A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant WomenJanssen Scientific Affairs, LLC · completed · HIV, HIV Infections, Pregnancy · study director
- Ph1NCT00821782 · Evaluation of Bacteria in the Mouth and Throat of Healthy Adults Before and After the Administration of Either Levofloxacin or Azithromycin, Both Antibiotic MedicationsOrtho-McNeil Janssen Scientific Affairs, LLC · completed · Healthy Volunteer · study director
- Ph3NCT00814580 · Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder SurgeryOrtho-McNeil Janssen Scientific Affairs, LLC · completed · Postoperative Pain · study director
- Ph4NCT00799487 · CONCERTA Lab School StudyOrtho-McNeil Janssen Scientific Affairs, LLC · completed · Attention Deficit Hyperactivity Disorder · study director
- Ph4NCT00799409 · Lab School Day Study for CONCERTA of Older Children With ADHDOrtho-McNeil Janssen Scientific Affairs, LLC · completed · Attention Deficit Hyperactivity Disorder · study director
- Ph3NCT00771758 · Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With OsteoporosisOrtho-McNeil Janssen Scientific Affairs, LLC · completed · Back Pain · study director
- Ph1NCT00771524 · Pharmacokinetic Study of the Penetration of Ceftobiprole in the BoneBasilea Pharmaceutica · completed · Total Hip Replacement Surgery · study director
- Ph4NCT00745901 · Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active FemalesOrtho-McNeil Janssen Scientific Affairs, LLC · completed · Contraception · study director
- N/ANCT00737269 · A Complicated Skin and Soft-tissue Infection Patient RegistryOrtho-McNeil Janssen Scientific Affairs, LLC · completed · Staphylococcal Skin Infections, Diabetic Foot Infections, Surgical Wound Infection · study director
- Ph3NCT00563459 · Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.SK Life Science, Inc. · terminated · Epilepsy, Seizures · study director
- Ph4NCT00535145 · Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver DiseaseOrtho-McNeil Janssen Scientific Affairs, LLC · completed · Schizophrenia, Schizoaffective Disorder, Psychotic Disorders · study director
- Ph2NCT00524056 · A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential TremorSK Life Science, Inc. · completed · Essential Tremor, Movement Disorders · study director
- N/ANCT00508547 · Psoriasis Longitudinal Assessment and RegistryJanssen Scientific Affairs, LLC · active not recruiting · Psoriasis · study director
- Ph2NCT00505258 · Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus BacteremiaBasilea Pharmaceutica · withdrawn · Bacteremia · study director
- N/ANCT00488891 · The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With SchizophreniaOrtho-McNeil Janssen Scientific Affairs, LLC · terminated · Schizophrenia · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.